ATE375987T1 - Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel - Google Patents

Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel

Info

Publication number
ATE375987T1
ATE375987T1 AT00962760T AT00962760T ATE375987T1 AT E375987 T1 ATE375987 T1 AT E375987T1 AT 00962760 T AT00962760 T AT 00962760T AT 00962760 T AT00962760 T AT 00962760T AT E375987 T1 ATE375987 T1 AT E375987T1
Authority
AT
Austria
Prior art keywords
arylmethyl
carbonylamino
tumor agents
thiazole derivatives
thiazole
Prior art date
Application number
AT00962760T
Other languages
English (en)
Inventor
Paolo Pevarello
Raffaella Amici
Manuela Villa
Barbara Salom
Anna Vulpetti
Mario Varasi
Original Assignee
Pfizer Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Italia Srl filed Critical Pfizer Italia Srl
Application granted granted Critical
Publication of ATE375987T1 publication Critical patent/ATE375987T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
AT00962760T 1999-08-12 2000-08-11 Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel ATE375987T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,832 US6114365A (en) 1999-08-12 1999-08-12 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents

Publications (1)

Publication Number Publication Date
ATE375987T1 true ATE375987T1 (de) 2007-11-15

Family

ID=23469806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962760T ATE375987T1 (de) 1999-08-12 2000-08-11 Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel

Country Status (36)

Country Link
US (3) US6114365A (de)
EP (1) EP1204649B1 (de)
JP (1) JP4864260B2 (de)
KR (2) KR100773709B1 (de)
CN (1) CN100410245C (de)
AP (1) AP1853A (de)
AT (1) ATE375987T1 (de)
AU (1) AU782882B2 (de)
BG (1) BG65484B1 (de)
BR (1) BR0013281A (de)
CA (1) CA2381097C (de)
CY (1) CY1107108T1 (de)
CZ (1) CZ303138B6 (de)
DE (1) DE60036803T2 (de)
DK (1) DK1204649T3 (de)
EA (1) EA005375B1 (de)
EE (1) EE04939B1 (de)
ES (1) ES2295056T3 (de)
GE (1) GEP20053475B (de)
HK (1) HK1054233B (de)
HR (1) HRP20020127B1 (de)
HU (1) HUP0202492A3 (de)
IL (2) IL147924A0 (de)
IS (1) IS2594B (de)
MA (1) MA25433A1 (de)
MX (1) MXPA02001508A (de)
NO (1) NO323576B1 (de)
NZ (1) NZ517236A (de)
OA (1) OA12047A (de)
PT (1) PT1204649E (de)
RS (1) RS50300B (de)
SI (1) SI1204649T1 (de)
SK (1) SK287373B6 (de)
UA (1) UA72538C2 (de)
WO (1) WO2001014353A1 (de)
ZA (1) ZA200201117B (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6407103B2 (en) 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
RU2312860C2 (ru) 1999-04-15 2007-12-20 Бристол-Маерс Сквибб Компани Циклические ингибиторы протеинтирозинкиназ
US6114365A (en) * 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6291504B1 (en) 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
CA2430151A1 (en) * 2000-11-27 2002-06-20 Pharmacia Italia S.P.A. Phenylacetamido- pyrazole derivatives and their use as antitumor agents
WO2002044174A2 (en) * 2000-12-01 2002-06-06 Bristol-Myers Squibb Pharma Company 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors
CA2430376A1 (en) 2000-12-08 2002-06-13 David J. Carini Semicarbazides and their uses as cyclin dependent kinase inhibitors
ATE318812T1 (de) * 2000-12-21 2006-03-15 Bristol Myers Squibb Co Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
EP1256578B1 (de) * 2001-05-11 2006-01-11 Pfizer Products Inc. Thiazolderivate und ihre Verwendung als cdk-Inhibitoren
IL159570A0 (en) * 2001-07-19 2004-06-01 Pharmacia Italia Spa Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
EP1724270A3 (de) 2001-07-19 2007-01-03 Pfizer Italia S.r.l. Phenylacetamido-thiazole Verbindungen, Verfahren zu ihren Herstellung und ihre Anwendung als antitumor Mittel
DE60233420D1 (de) * 2001-09-27 2009-10-01 Equispharm Co Ltd Fumagillolderivate und verfahren zu deren herstellung
CZ2004747A3 (cs) * 2001-12-21 2004-11-10 Novo Nordisk A/S Deriváty amidů jako GK aktivátory
JP4881559B2 (ja) * 2002-06-27 2012-02-22 ノボ・ノルデイスク・エー／エス 治療薬としてのアリールカルボニル誘導体
MXPA05008520A (es) * 2003-02-12 2005-10-20 Pfizer Derivados de 2-(sulfo-fenil)-aminotiazol antiproliferativos.
EP1597256A1 (de) * 2003-02-21 2005-11-23 Pfizer Inc. N-heterocyclylsubstituierte aminothiazolderivate als proteinkinaseinhibitoren
CA2520957C (en) * 2003-03-31 2013-08-06 Sucampo Ag Method for treating vascular hyperpermeable disease
FR2857664B1 (fr) * 2003-07-15 2007-12-14 Oreal Nouveaux derives thiazoles et utilisation de ces derives pour la teinture des fibres keratiniques
WO2005014591A1 (en) * 2003-07-15 2005-02-17 L'oreal 2-acylamino or 2-sulfonylamino-1, 3-thiazoles as couplers for the oxidation dyeing of keratin fibres
US7351727B2 (en) * 2003-09-02 2008-04-01 Bristol-Myers Squibb Company Inhibitors of 15-lipoxygenase
US20050074424A1 (en) * 2003-10-03 2005-04-07 Lev Salnikov Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method
US20070196395A1 (en) * 2003-12-12 2007-08-23 Mackerell Alexander Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
DK1723128T3 (da) * 2004-01-06 2013-02-18 Novo Nordisk As Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
EP1763345A2 (de) 2004-06-18 2007-03-21 GPC Biotech Inc. Kinase-hemmer zur behandlung von krebs
EP1621536A1 (de) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Amino zyklische Urea-Derivaten, ihre Herstellung und deren pharmazeutische Verwendungen als Kinase Inhibitoren
EP1621539A1 (de) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Heterocyclische-substituirte cyclische Harnstoffderivate, Verfaren zu ihrer Herstellung, und ihre pharmaceutische Verwendung als Kinase Inhibitoren
US7410988B2 (en) * 2004-08-13 2008-08-12 Genentech, Inc. 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
ATE432921T1 (de) 2004-12-23 2009-06-15 Gpc Biotech Ag Quadratsäurederivate mit antiproliferativer wirkung
BRPI0611187A2 (pt) * 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
ES2382815T3 (es) * 2005-07-08 2012-06-13 Novo Nordisk A/S Dicicloalquilcarbamoil ureas como activadores de glucoquinasa
CA2615938C (en) 2005-07-14 2014-04-29 Novo-Nordisk A/S Urea glucokinase activators
EP1914234A1 (de) * 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidinen und ihre Verwendung als kinase Inhibitoren
WO2008084043A1 (en) * 2007-01-09 2008-07-17 Novo Nordisk A/S Urea glucokinase activators
EP2099777B1 (de) * 2007-01-11 2015-08-12 Novo Nordisk A/S Harnstoff-glucokinase-aktivatoren
ES2522169T3 (es) * 2007-02-13 2014-11-13 Ab Science Forma polimorfa de derivado de 2-amino (nitroaril) tiazol
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
TWI437986B (zh) * 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2112152A1 (de) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones als Plk-Inhibitoren
EP2112150B1 (de) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Verbesserte Raf-Inhibitoren
CA2743717A1 (en) 2008-11-13 2010-05-20 Link Medicine Corporation Azaquinolinone derivatives and uses thereof
UA103918C2 (en) * 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
TWI504598B (zh) * 2009-03-20 2015-10-21 Onyx Therapeutics Inc 結晶性三肽環氧酮蛋白酶抑制劑
EP2440556A1 (de) * 2009-06-10 2012-04-18 Vertex Pharmaceuticals Incorporated Phosphatidylinositol 3-kinasehemmer
DE102009043260A1 (de) * 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
EP2325185A1 (de) 2009-10-28 2011-05-25 GPC Biotech AG Plk-Inhibitor
HU0900798D0 (en) 2009-12-21 2010-03-01 Vichem Chemie Kutato Kft 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
US8883793B2 (en) 2010-12-29 2014-11-11 Development Center For Biotechnology Tubulin inhibitors and methods of using the same
RU2011122942A (ru) 2011-06-08 2012-12-20 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Новые ингибиторы киназ
CN103387551B (zh) 2012-05-11 2015-05-20 中国人民解放军军事医学科学院毒物药物研究所 噻唑类化合物及其用途
US9617225B2 (en) 2012-08-23 2017-04-11 Virostatics Srl 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity
ES2935185T3 (es) 2016-04-11 2023-03-02 Genfit Métodos para el tratamiento de enfermedades fibróticas
CN111727042A (zh) 2017-12-06 2020-09-29 仁新医药私人有限公司 微管蛋白抑制剂
US11472774B2 (en) 2018-02-01 2022-10-18 The University Of Sydney Anti-cancer compounds
WO2019241089A1 (en) 2018-06-12 2019-12-19 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020193431A1 (en) 2019-03-22 2020-10-01 Deutsches Krebsforschungszentrum Novel inhibitors of histone deacetylase 10
EP3712127A1 (de) 2019-03-22 2020-09-23 Deutsches Krebsforschungszentrum Neuartige inhibitoren der histon-deacetylase 10
WO2021162054A1 (ja) * 2020-02-10 2021-08-19 学校法人順天堂 ２型リアノジン受容体活性抑制剤
CN115322208B (zh) * 2021-05-10 2023-04-11 中国药科大学 2-氨基噻唑类衍生物及其制备方法和医药用途
WO2023182780A1 (ko) * 2022-03-22 2023-09-28 오토텔릭바이오 주식회사 티아졸 유도체 화합물 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL263812A (de) * 1960-04-20
JPH1095777A (ja) * 1996-07-31 1998-04-14 Otsuka Pharmaceut Co Ltd チアゾール誘導体
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
ES2267873T3 (es) * 1997-10-27 2007-03-16 Agouron Pharmaceuticals, Inc. Derivados de 4-aminotiazol, su preparacion y uso como inhibidores de kinasas dependientes de ciclina.
US6040321A (en) 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
DE69923681T2 (de) * 1998-06-18 2006-01-12 Bristol-Myers Squibb Co. Kohlenstoff substituierte aminothiazole als inhibitoren von cyclin-abhängigen kinasen
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
RU2312860C2 (ru) * 1999-04-15 2007-12-20 Бристол-Маерс Сквибб Компани Циклические ингибиторы протеинтирозинкиназ
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6992081B2 (en) * 2000-03-23 2006-01-31 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
SE0102440D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compound
DE60221627D1 (de) * 2001-12-21 2007-09-20 Virochem Pharma Inc Thiazolderivate und ihre Verwendung zur Behandlung oder Vorbeugung von Infektionen durch Flaviviren
CA2514573A1 (en) * 2003-01-27 2004-08-12 Astellas Pharma Inc. Thiazole derivatives and their use as vap-1 inhibitors

Also Published As

Publication number Publication date
JP2003507461A (ja) 2003-02-25
DE60036803T2 (de) 2008-07-24
AU7440000A (en) 2001-03-19
EA200200247A1 (ru) 2002-08-29
SI1204649T1 (sl) 2008-02-29
YU9702A (sh) 2004-11-25
EA005375B1 (ru) 2005-02-24
US20050004120A1 (en) 2005-01-06
CA2381097A1 (en) 2001-03-01
NO20020683D0 (no) 2002-02-11
US6114365A (en) 2000-09-05
CA2381097C (en) 2009-06-16
NO20020683L (no) 2002-04-10
DE60036803D1 (de) 2007-11-29
WO2001014353A1 (en) 2001-03-01
CN100410245C (zh) 2008-08-13
HRP20020127B1 (en) 2010-08-31
EP1204649A1 (de) 2002-05-15
UA72538C2 (en) 2005-03-15
CN1425009A (zh) 2003-06-18
ES2295056T3 (es) 2008-04-16
JP4864260B2 (ja) 2012-02-01
EE04939B1 (et) 2007-12-17
IL147924A (en) 2008-03-20
GEP20053475B (en) 2005-03-25
BG65484B1 (bg) 2008-09-30
IS2594B (is) 2010-03-15
AU782882B2 (en) 2005-09-08
HK1054233B (zh) 2009-05-29
PL353588A1 (en) 2003-12-01
HK1054233A1 (en) 2003-11-21
OA12047A (en) 2006-05-02
IS6264A (is) 2002-02-11
SK287373B6 (sk) 2010-08-09
BG106481A (en) 2002-09-30
HRP20020127A2 (en) 2003-04-30
IL147924A0 (en) 2002-08-14
MA25433A1 (fr) 2002-04-01
NZ517236A (en) 2004-11-26
KR20070074003A (ko) 2007-07-10
KR20020060159A (ko) 2002-07-16
DK1204649T3 (da) 2007-12-03
ZA200201117B (en) 2003-04-30
BR0013281A (pt) 2002-06-18
RS50300B (sr) 2009-09-08
AP2002002441A0 (en) 2002-03-31
CZ2002486A3 (cs) 2002-11-13
MXPA02001508A (es) 2003-07-21
SK1802002A3 (en) 2003-05-02
KR100773709B1 (ko) 2007-11-09
HUP0202492A2 (hu) 2002-11-28
PT1204649E (pt) 2008-01-10
EP1204649B1 (de) 2007-10-17
US6784198B1 (en) 2004-08-31
CZ303138B6 (cs) 2012-04-25
AP1853A (en) 2008-05-29
EE200200064A (et) 2003-04-15
CY1107108T1 (el) 2012-10-24
KR100827563B1 (ko) 2008-05-07
NO323576B1 (no) 2007-06-11
HUP0202492A3 (en) 2004-12-28

Similar Documents

Publication Publication Date Title
ATE375987T1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE60039539D1 (de) 4-aminopiperidin-derivate und ihre verwendung als arzneimittel
ATE299503T1 (de) Pyridin-3-carbonsäurederivate und ihre verwendung als zwischenprodukte
DE59710422D1 (de) Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
ATE254123T1 (de) Benzazolderivate und ihre verwendung als jnk modulatoren
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
DE60139477D1 (de) 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel
ATE348805T1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
ATA5422000A (de) Oximderivate und ihre verwendung als latente säuren
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
DE69921124D1 (de) Imidazolderivate und ihre verwendung als somatostatin rezeptorliganden
DE60016326D1 (de) Wasser-absorbierende Zusammensetzung und ihre Verwendung
DE50008597D1 (de) Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
DE69818248D1 (de) Chinolin- und chinazolin-derivate als crf antagonisten
DE69826693D1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
EE200200135A (et) D4 antagonistidena toimivad tienoisoksasolüül- jatienüülpürrasolüülfenoksü-asendatud propüülderivaadid
DE60037183D1 (de) Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
ATE221529T1 (de) Oxadiazolinderivate und ihre verwendung als insektizide
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
ATE264315T1 (de) Aminothiazolderivate und ihre verwendung als crf- rezeptor-liganden
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
DE69811018T2 (de) Triazol-Derivate und ihre Verwendung als antimykotische Mittel
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204649

Country of ref document: EP

EEIH Change in the person of patent owner